Janine Thomas appointed Commissioner Editor in Documentaries

WEBWIRE

Janine Thomas, has been appointed as Commissioning Editor and will directly report to Head of Documentaries Alisa Pomeroy. She will support Rita Daniels by taking on the day-to-day running ofthe career defining strand First Cut, freeing up Daniels to focus on new blue-chip documentary series.Janines other responsibilities will include working with on and off screen talent.

She joins from Sky UK where she delivered a string of shows across the pay-TV broadcasters Documentaries, Crime and Nature channels. Highlights included ArrowPictures Grierson and Edinburgh nominated Positive: 30 Years Of HIV In Britain,Minnows Mother Teresa, Top Hats BroadcastDigital Award-nominated Look Away, Lion TVsArctic From Above With Liz Bonnin and Blast!s Italia 90 series.

Janine has also made her mark by nurturing off-screen talent with her launch of the DocShorts Initiative. The scheme offered emerging film-makers with disabilities and those from ethnic minority backgrounds access to a 500,000 fund to direct cinematic short films.Previously at Channel 4, Janine was Documentaries Assistant Editor and worked across a diverse slate including, Damilola:The Boy Next Door, Secret Life of the Zoo and 24 Hours in A&E.Additionally she commissioned into the digital Factual strand True Stories and E4.She also championed Black History Month programming, such as Gal-dem presents;Black British History, comedian Mo Gilligans Black British & Funny and the film series Take Your Knee off my Neck, a response to the killing of George Floyd.

Janine Thomas, Commissioning Editor said:I am thrilled to be joining the award-winning Documentaries team. Without doubt this is an exciting opportunity to continue the storytelling legacy of First Cut.I will look forward to working with Rita Daniels on this strand and aim to develop distinctive and uniquely Channel 4 programmes with new on and off-screen talent.

Alisa Pomeroy, Head of Documentaries added: Janine is a rising star and Im delighted that she will be joining the Documentaries team and working across one of our most cherished strands. She has a great reputation for working with new talent on and off screen which I am sure will lead to First Cut delivering some incredible programming from the next generation of directors.

For First Cut Rita Daniels has been responsible formentoring and nurturing the next generation of story tellers. Since 2016 she has placed a host of emerging filmmakers on the stage at Sheffields Doc Fest First Cut live pitches.Those she has worked with include:Ashley Francis-RoyFirst Cut winner for 2019 has received a Edinburgh New Voices Award, an RTS award and a Bafta nomination for his First Film The Real EastEnders.He then went on to direct the multi-award winningDamilola, the Boy Next Doorand is currently working onThe Real Line of Dutywith Story Films (wt).Ashley was also Bafta Breakthrough winner for 2021.Others includeLyttanya Shannonwho after making her high rating First Cut,Sun, Sea and Surgerywent on to direct onHospitaland thenAmbulanceand recently madeSubnormalwithSteveMcQueen as exec producer andThe Black Maternity Scandalfor C4.She was also the Bafta Breakthrough winner for 2021 .Also in the mix,Chloe Fairweather.First Cut FilmI Do At 92who most recently made the Oscar nominated feature docDying to Divorce.

Ann Silverman Health Clinic Executive Director Announces Retirement After 50 Years of Public Health Service

She has been at the forefront of providing health care for the underserved in Bucks County for the past 50 years. During her tenure at the Ann Silverman clinic, she led the expansion of its programs and facilities to fulfill its mission of providing free medical, dental and behavior health services to low-income and uninsured families in the community.

As executive director since 2016, Fabian-Oresic met every public health challenge and opportunity with passion and energy. As other community health clinics in Bucks County closed, she expanded the programs and services at the Ann Silverman Clinic, which is the only remaining free clinic in Bucks County.

Under her leadership, Fabian-Oresic secured the clinics future with successful fundraising initiatives to support its programmatic growth and construction of larger facilities to accommodate the new services.

Sallys retirement will mark the last chapter of a remarkable public health career, said Paul Edgerton, Board chair of the Ann Silverman Health Clinic. She has led the clinic with a clear focus on improving the health of our patients and approached her work with compassion and a collaborative spirit. We are very grateful that shes put the clinic on a great path to ensure our important work continues.

The impact of Fabian-Oresics legacy is immediate and will be enduring. The comprehensive medical care that she built is provided by first-rate clinicians and a robust network of volunteer physicians from internists to specialists, including orthopedics and ophthalmology. She led the expansion of the dental clinic to include both preventative and restorative care.

She established for the first time a behavioral health program, with both English and Spanish-speaking counselors, as there is significantly limited access to mental health services for the uninsured.

During the COVID-19 pandemic, Fabian-Oresic faced the most challenging time in her career as the clinics patients were disproportionately at risk for infection and hard hit by job losses, closed schools, and food insecurity. She quickly mobilized the clinic to pivot to telehealth visits and organized vaccination clinics that protected nearly 900 people, with the assistance of Doylestown Health.

Despite the urgent medical needs, Fabian-Oresic made it a priority to address food insecurity patients faced by securing more than $90,000 in grocery gift cards.

I am enormously grateful for the opportunities to live out my passion for public health these past 50 years, said Fabian-Oresic. Ive been fortunate to serve with some of the most dedicated caregivers and leaders in health care, and although I will retire this summer, my commitment to community health will never waver. I will always support efforts to make the world a better place for all. I am, however, very excited to be able to spend more time with my family and granddaughter.

Prior to joining the Ann Silverman Health Clinic, Fabian-Oresic served 16 years as the executive director of the Bucks County Health Improvement Partnership (BCHIP), a nonprofit collaborative partnership initiative of the County of Bucks, the hospitals located in Bucks County, and the Bucks County Medical Society. Sally was selected as its first executive director. While there, she directed two free clinics, developed tobacco education and cessation programs, initiated an advanced care planning program with five hospitals, and helped create the Domestic Violence Awareness Task Force and the Bucks County Child Advocacy Center.

For the first 27 years of her career, Fabian-Oresic worked at the Bucks County Department of Health where she started as a staff nurse and advanced to become director of Personal Health and Nursing Services for her last 10 years. As director, she managed a 70+ nursing, nutrition, and support staff; vaccination clinics; TB, HIV/AIDS and well child services; the Women, Infant and Childrens Supplemental Food Program (WIC); and investigated communicable disease cases and outbreaks.

Her awards include Family Builder of the Year Awardee from the Family Association of Bucks County and Woman Who Make a Difference Honoree from the Bucks County March of Dimes. She served as Secretary and Vice Chair of the Free Clinic Association of Pennsylvania, and as an officer of the Pennsylvania Public Health Association.

Fabian-Oresic was born and raised in Doylestown, and received her bachelors in Nursing from Keuka College, NY, and her masters in Nursing Administration and Community Health from Villanova University. She is an avid skier, swimmer and enjoys hiking and relaxing on the New Jersey shore.

About the Ann Silverman Community Health Clinic
The Ann Silverman Community Health Clinic is a 501(c)(3) nonprofit that provides free medical, dental, and behavioral health care and social services to low-income, uninsured families in Bucks County. The clinic is made possible by volunteer physicians, dentists, nurses, and support staff; Doylestown Health, which contributes facilities, and other support services; and generous donations from the community Visit us at www.aschealthclinic.org and follow us on facebook.com/ann-silverman-community-health-clinic and instagram.com/annsilvermanclinic.

###

Driving Successful Lives Ends 2022 with Organizational Record for Real Estate Donations

The non-profit organization announces a record level of real estate donations for the year

According to a representative for Driving Successful Lives, the organization witnessed a new record for real estate donations to the non-profit during the 2022 fiscal year. “In reviewing all of the donations made during this last year, we were elated to discover that the dollar value and number of donations for the year have surpassed every other year the DSL has been in operation,” said the representative.

“This is very exciting to us on so many levels – especially during a period where our nation is slowly recovering from a pandemic and lingering in a certain degree of economic uncertainty. This new record for real estate donations also represents a drastic increase in the amount of good that Driving Successful Lives was able to accomplish during the year, and will be able to continue to do going forward. These donations represent an ongoing mission that we able to carry out – not for one year, but for many years – considering how we provide direct housing with some properties and sell other properties to fund more and more giving & support to needy families and individuals.’

If you wish to pay it forward and provide a conduit for help for DSL in its mission to help as many families as possible, visit https://drivingsuccessfullives.org/real-estate-state to find out how you can help others, while realizing beneficial tax advantages along with the satisfaction of having made a change in the world.

For More Information Visit: https://drivingsuccessfullives.org/real-estate-state

About Driving Successful Lives

Driving Successful Lives’ mission is to facilitate car donations so that veterans, homeless families, children, those with addictions & other non-profits can benefit from fellow citizens giving-forward.

Every time a person gives to the charity of their choice it may also create a tax benefit for them. The money, the items, and the real property that they have donated to non-profit institutions throughout the tax year may be tax deductible which means that they could end up being the difference between a good tax return and a great tax return. Depending upon the kind of donation and the type of charity or foundation that they chose to donate to, the tax deduction it creates could be very helpful for reducing the amount taxes that they owe. Many successful and wealthy people state that at least to a certain degree, a part of whom they are and what they have become comes at least in part from the practice of giving. Contributing to charities can be a very convenient way to reduce taxes.

Visit: https://www.drivingsuccessfullives.com/

Japan – Eisai Submits Supplemental Biologics License Application to FDA for Traditional Approval of LEQEMBI (lecanemab-irmb) for the Treatment of Alzheimer’s Disease

Eisai Co., Ltd. and Biogen Inc. announced Eisai has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) supporting the conversion of the Accelerated Approval of LEQEMBI (lecanemab-irmb) 100 mg/mL injection for intravenous use to a traditional approval. This sBLA is subject to validation of whether the FDA accepts the application for review. LEQEMBI is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble (“protofibrils”)* and insoluble forms of amyloid beta (Abeta), approved under Accelerated Approval Pathway by the FDA on January 6, 2023, for the treatment of Alzheimer’s Disease (AD). Treatment with LEQEMBI should only be initiated in patients with the mild cognitive impairment or mild dementia stage of disease and confirmed presence of Aβ pathology.

Accelerated Approval of LEQEMBI was based on Phase 2 data that demonstrated LEQEMBI reduced the accumulation of Aβ plaque in the brain, a defining feature of AD. Continued approval for this indication is contingent upon verification of LEQEMBI’s clinical benefit in a confirmatory trial. The sBLA for LEQEMBI is based on the data from the Phase 3 confirmatory Clarity AD clinical trial. In Clarity AD, LEQEMBI met the primary endpoint and all key secondary endpoints with highly statistically significant results, and the profile of Amyloid-Related Imaging Abnormalities (ARIA) incidence was within expectations. In November 2022, the results of the Clarity AD study were presented at the 2022 Clinical Trials on Alzheimer’s Disease (CTAD) conference, and simultaneously published in the New England Journal of Medicine, peer-reviewed medical journals.

“We deeply appreciate the cooperation of people living with Alzheimer’s disease and healthcare professionals who participated in LEQEMBI’s Phase 3 Clarity AD clinical study, which enabled us to submit this sBLA. Alzheimer’s disease causes significant impairment and burden to both the people living with this disease and their families, as well as having a profound impact on society,” said Haruo Naito, Chief Executive Officer at Eisai. “The fact that Eisai was able to file LEQEMBI’s supplemental Biologics License Application for traditional FDA approval on the same day we received accelerated approval demonstrates our commitment to the Alzheimer’s disease community and is a major step forward in ensuring access for all those in the U.S living with this disease in need of this medicine. We will continue to actively cooperate with the FDA’s review.”

Eisai has initiated submission of data for BLA to the National Medical Products Administration (NMPA) of China in December 2022. Eisai plans to file for marketing authorization applications of lecanemab in Japan and EU by the end of Eisai’s FY2022, which ends March 31, 2023.

“Today’s filing is an important milestone for people living with Alzheimer’s disease, demonstrating the resilience of the scientific and medical communities in their fight against this terrible disease despite the many setbacks and the challenges they’ve faced,” said Christopher A. Viehbacher, President and Chief Executive Officer of Biogen. “We commend Eisai for their leadership on the development of lecanemab and for the speed in which they were able to complete this filing, which is based on important new data from the pivotal late-stage Clarity AD study.”

Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with both Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making authority.

* Protofibrils are large Abeta aggregated soluble species of 75-500 Kd. 1, 2
To learn more, visit www.LEQEMBI.com.

For more information, visit www.eisai.com/news/2023/pdf/enews202304pdf.pdf.

Copyright ©2023 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.

BizPal® Introduces New Direct Thermal Label Printer – DTP-1000

Today, BizPal LLC, an innovative technology company, is proud to introduce its newest product, the DTP-1000 Direct Thermal Printer. This high-speed 4×6 label printer is designed to meet the needs of a variety of users, including those requiring shipping labels, barcode labels, and household labels.

Middletown, Delaware – WEBWIRE

Today, BizPal LLC, an innovative technology company, is proud to introduce its newest product, the DTP-1000 Direct Thermal Printer. This high-speed 4×6 label printer is designed to meet the needs of a variety of users, including those requiring shipping labels, barcode labels, and household labels. It is a multi-functional printer that can print labels up to 4.25 wide and 70 long. Whats more, it is compatible with Windows, Mac, and Linux systems. With its rich emulation language compatibility and support for most 1D/2D barcodes, it is the perfect choice for printing labels, shipping labels, barcode labels, and more.

Below is the overview of the newly released Direct Thermal Printer:

The DTP-1000 has a modern, sleek design that is both space-saving and aesthetically pleasing. It has one multi-functional button and one two-colour indicator, making it simple to operate. The printer is also equipped with an 8MB RAM and 8MB Flash memory for more flexible usage.

The DTP-1000 is capable of achieving a high printing speed of 152 mm (6″)/s Max and a high resolution of 203 dpi. It is also equipped with an intelligent control system for the print head temperature, ensuring the printer produces stable and consistent output. Additionally, it uses direct thermal technology, eliminating the need for refilling ink toner and helping to save time and money.

The printer also features a rich emulation language compatibility that includes TSPL, ZPL, EPL, and DPL. It is compatible with most 1D/2D barcodes, making it ideal for printing labels with barcodes. Both fanfold paper and roll paper loaded from the back of the printer are supported. It is also compatible with most common labels of varying sizes, including 4×6, 4×8.25, 4×6.75,4×4 4×3, 4×2, 4×1, 3×2, 2.25×1.25″, and 2×1.

The Direct Thermal Printer is a high-performance printer that is designed to meet the needs of businesses and individuals alike. It is capable of producing high-quality prints with a resolution of up to 600 x 1200 dpi and a print speed of up to 8 pages per minute.

The Direct Thermal Printer is highly efficient, utilizing direct thermal technology to produce crisp, clear prints without the use of toner or ink. This makes it an ideal choice for businesses and individuals who need a reliable, cost-effective printing solution.

Customers can now buy the DTP-1000 Direct Thermal Printer directly on Amazon: https://www.amazon.com/gp/product/B0BBVP37KX

About BizPal
BizPal, a reputable manufacturer of cutting-edge goods for companies and consumers, was established in the United States. Enabling companies and customers to optimize their own performance, processes, and workflows.

BizPal is dedicated to providing customers with reliable, innovative technology solutions. With the introduction of the DTP-1000 Direct Thermal Printer, BizPal is once again demonstrating its commitment to providing customers with user-friendly products that are designed to meet their needs.

We are excited to offer the DTP-1000 Direct Thermal Printer, and we look forward to seeing how it can improve the efficiency and effectiveness of our customers operations.

For more information, please visit our website at https://bizpalsupplies.com/